Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles 90033, California, USA.
Retrovirology. 2010 Jan 26;7:4. doi: 10.1186/1742-4690-7-4.
The gibbon ape leukemia virus (GaLV) Env protein mediates entry into a wide range of human cells and is frequently used to pseudotype retroviral vectors. However, an incompatibility exists between GaLV Env and lentiviral vectors that results in decreased steady-state levels of the mature GaLV Env in cells and prevents its incorporation into lentiviral vector particles.
We identified the HIV-1 Vpu protein as the major cause of the depletion in GaLV Env levels that occurs when lentiviral vector components are present. This activity of Vpu targeted the mature (cleaved) form of the GaLV Env that exists within or beyond the trans-Golgi. The activity required two conserved phospho-serines in the cytoplasmic tail of Vpu that are known to recruit beta TrCP, a substrate adaptor for an SCF E3 ubiquitin ligase complex, and could be blocked by mutation of lysine 618 in the GaLV Env tail. Moreover, the Vpu-mediated decrease of GaLV Env levels was inhibited by the lysosomal inhibitor, bafilomycin A1. Interestingly, this activity of Vpu was only observed in the presence of other lentiviral vector components.
Similar to the mechanism whereby Vpu targets BST-2/tetherin for degradation, these findings implicate beta-TrCP-mediated ubiquitination and the endo-lysosomal pathway in the degradation of the GaLV Env by lentiviral vector components. Possibly, the cytoplasmic tail of the GaLV Env contains features that mimic bona fide targets of Vpu, important to HIV-1 replication. Furthermore, the lack of effect of Vpu on GaLV Env in the absence of other HIV-1 proteins, suggests that a more complex interaction may exist between Vpu and its target proteins, with the additional involvement of one or more component(s) of the HIV-1 replication machinery.
长臂猿猿白血病病毒 (GaLV) Env 蛋白介导进入广泛的人类细胞,并且经常用于假型逆转录病毒载体。然而,GaLV Env 与慢病毒载体之间存在不兼容性,导致细胞中成熟 GaLV Env 的稳态水平降低,并阻止其掺入慢病毒载体颗粒中。
我们确定 HIV-1 Vpu 蛋白是导致存在慢病毒载体成分时 GaLV Env 水平降低的主要原因。Vpu 的这种活性针对存在于反式高尔基体内部或外部的成熟(切割)形式的 GaLV Env。该活性需要 Vpu 细胞质尾部中的两个保守磷酸丝氨酸,这些丝氨酸已知募集βTrCP,即 SCF E3 泛素连接酶复合物的底物衔接蛋白,并且可以通过突变 GaLV Env 尾部中的赖氨酸 618 来阻断。此外,Vpu 介导的 GaLV Env 水平降低可被溶酶体抑制剂巴弗洛霉素 A1 抑制。有趣的是,只有在存在其他慢病毒载体成分的情况下,Vpu 才会表现出这种活性。
类似于 Vpu 靶向 BST-2/tetherin 进行降解的机制,这些发现表明β-TrCP 介导的泛素化和内体溶酶体途径参与了慢病毒载体成分对 GaLV Env 的降解。可能 GaLV Env 的细胞质尾部包含模拟 Vpu 的真正靶标的特征,这对 HIV-1 复制很重要。此外,在不存在其他 HIV-1 蛋白的情况下,Vpu 对 GaLV Env 没有影响,这表明 Vpu 与其靶蛋白之间可能存在更复杂的相互作用,可能涉及 HIV-1 复制机制的一个或多个成分。